Kidney failure is up to five times more common in people from minority ethnic backgrounds1, yet many face significant barriers to accessing appropriate care. Language barriers, cultural stigma, religious concerns, and mistrust in healthcare all contribute to poorer kidney health outcomes and lower rates of organ donation within communities. With World Kidney Day on 14 […]
Read More… from Minority ethnic communities face greater kidney health risks
Antibody-mediated rejection (AMR) is one of the most common causes of kidney transplant failure. To date, however, no treatment has proven effective in combating this complication in the long term. As part of an international and multidisciplinary clinical study led by Georg Böhmig and Katharina Mayer, Clinical Division of Nephrology and Dialysis, Department of Medicine […]
Read More… from Kidney transplantation: New therapy proven effective
A team of European researchers has developed a new test that can accurately measure biological ageing in a clinical setting. The discovery was made while studying patients for the aging effects of chronic kidney disease. The new test is an epigenetic clock – a type of biochemical assessment that looks at DNA to understand how […]
Read More… from Most accurate test to date developed to measure biological ageing
In a new clinical study at Karolinska University Hospital, the first patient has been treated with a drug whose active ingredient comes from one of Sweden’s most poisonous mushrooms. The purpose of the clinical phase I/II trial is to study whether this can become a treatment for patients with metastatic kidney cancer. Several species of […]
Read More… from Medicine extracted from poisonous mushrooms tested against kidney cancer
A major clinical trial has found a simple change to world practice for kidney transplants could deliver real benefits for recipients and reduce their need for dialysis by 25 per cent. The BEST-Fluids trial was conducted by the Australasian Kidney Trials Network (AKTN) in collaboration with researchers from The University of Queensland, The University of […]
Read More… from Major clinical trial set to change kidney transplant practice
New study reveals way to predict side-effect risk from common immune suppressant medication: A major new study has found a method to identify people who may experience blood, kidney, or liver related side-effects from methotrexate, the most commonly used immune-suppressing medicine with 1.3 million users in the UK. The method, known as ‘risk stratification’, predicts […]
Read More… from Risk satisfaction to predict abnormal blood results
The kidney and beyond webinar will take place on Sat 5 Sep 2020 from 1:30pm to 6 Sep 2020 at 10:00am This unique collaboration between the UK Renal Association SpR Club and The Royal Society of Medicine Nephrology Section, will explore issues of multi-system dysfunction and multi-morbidity in kidney diseases. For the first time, the SpR Club will be hosting one of […]